Speed Ticket11 Jul 2025 11:19
The Board of Futura Medical plc (AIM: FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, notes the recent increase in the Company's share price and, save for board changes and the proposed appointment of Alex Duggan as Interim CEO (subject to completion of due diligence) announced on the 8 July, the board advises that it knows of no reason for this rise.